Göttingen, July 2, 2024 Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret The long-standing CEO of Sartorius AG, Dr. Joachim Kreuzburg, has informed the company's Supervisory Board that after more than 20 years as CEO of the company, he will not be s [ … ]

Göttingen, Germany, May 16, 2024 Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA   Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery, and predictive design of manufacturing processe [ … ]

 Göttingen, Germany | May 13, 2024 Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification   Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing (ICB) platform Modular platform will combine highest flexibility with stand [ … ]

  Göttingen, April 18, 2024 Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed   Inventory reduction at customers further advanced; order intake increases by almost 10 percent in constant currencies Sales revenue down by 7.6  [ … ]

Göttingen, March 28, 2024 Resolutions of the Annual General Meeting of Sartorius AG At today’s virtual Annual General Meeting, the shareholders of Sartorius AG approved the proposals of the Executive Board and the Supervisory Board by a large majority, including the proposal to distribute a dividend of 0.74 euros per preference share and 0.73 euro [ … ]

Göttingen, February 16, 2024  Sartorius releases Annual Report for 2023 The life science group Sartorius has released its Annual Report for 2023 today. The document is available under the following link: https://ir-reports.sartorius.com/en/ag/fy-2023. Financial calendar  March 28, 2024     Annual General Meeting April 18, 2024       Publication of  [ … ]

Göttingen, February 9, 2024 The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG resolved at its meeting today to approve the recommendation of the Executive Board to submit a proposal to the Annual General Meeting on March 28, 2024, to pay a dividend of 0.74 euros per  [ … ]

Göttingen, January 26, 2024 Sartorius expects profitable growth in 2024; double-digit annual sales revenue growth projected through to 2028   Preliminary 2023 results in line with forecast: sales revenue in constant currencies down 16.6 percent; underlying EBITDA margin of 28.3 percent Demand recovery in both divisions in the fourth quarter: ord [ … ]